Triple therapy versus dual antiplatelet therapy for patients with atrial fibrillation and acute coronary syndromes: A systematic literature review.
CONCLUSION: In patients with ACS and AF, TT is likely to be associated with increased risk of bleeding, without a clear reduction in ischaemic endpoints. The quality of the evidence to support current guidelines for this patient group was generally poor.
PMID: 28969538 [PubMed - as supplied by publisher]
Source: Current Cardiology Reviews - Category: Cardiology Tags: Curr Cardiol Rev Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Databases & Libraries | Heart | Ischemic Stroke | Statistics | Stroke | Study